In a
first, scientists have grown a living bone in the lab to repair large defect in
the head and face of patient, taking a step forward in improving treatments for
people with craniofacial defects. A new technique developed, uses autologous
stem cells derived from a small sample of the recipient’s far and replicates
the original anatomical structures of the bone. The researchers have been able
to show, in a clinical-size porcine model of jaw repair, that this bone, grown
in vitro and then implanted, can seamlessly regenerate a large defect while
providing mechanical function. The quality of the regenerated tissue, including
vascularisation with blood perfusion, exceeds what has been achieved using
other approaches. Researchers fabricated a scaffold and bioreactor chamber
based on images of the jaw defect, to provide and anatomical fit. The scaffold
they built enabled bone formation without the use of growth factors, and also
provided mechanical function. They then isolated the recipient’s own stem cells
form a small fat aspirate and, in just three weeks, formed the bone within a
scaffold made from bone matrix, in a custom-designed per-fused bioreactor.
Sunday, 4 September 2016
Gravitational Waves Detected For 2nd Time By The Collision Of Two Black Holes
For the
second time, scientists have detected gravitational waves created by the collision
of two black holes 1.4 billion light years away, which once again confirms
Einstein’s theory of general relativity. The scientists detected the
gravitational waves – ripples through the fabric of the space-time continuum –
using the twin Laser Interferometer Gravitational-wave Observatory (LIGO)
interferometer in the US.
On December
26 last year, both detectors situated more 3,000 kilometer apart, picked up a
very faint signal amid the surrounding noise. While LIGO’s first detection,
reported on February 11 this year, produced a clear peak in the data, this
second signal was far subtler, generating a shallower waveform that was almost
buried in data. The researchers calculated that the gravitational wave arose
from the collision of two black holes, 14.2 and 7.5 times the mass of the Sun.
The signal
picked up by LIGO’s detector encompasses the final moments before the black holes
merged. In the final second, while the signal was detectable, the black holes
spun around each other 55 times, approaching half the speed of light, before
merging in a collision releasing a huge amount of energy in the form of
gravitational waves, equivalent to the mass of the Sun. This cataclysm, occurring
1.4 billion light years away, produced a more massive spinning black hole about
20.8 times the mass of the Sun. This second detection of gravitational waves
also successfully tested LIGO’s ability to detect incredibly subtle
gravitational signals.
LIGO’s
two interferometers, each four kilometres, are designed in such a way that each
detector stretches by an infinitesimal amount if a gravitational wave were to
pass through. On September 14 last year, the detectors picked up the very first
signal of a gravitational wave, which stretched each detector by as little as a
fraction of a proton’s diameter. Just four months later, LIGO recorded a second
signal, which stretched the detectors by an even smaller amount. In its first
four months, the advanced LIGO detectors have already detected two signals of
gravitational waves, produced by the collision of two very different binary
black hole systems.
To Combat Global Warming, Carbon Dioxide is Turned Into Stone
Scientists
have found a quick way – but not a cheap one – to turn heat-trapping carbon
dioxide gas into harmless rock. Experts say the results of a two-year, $10
million experiment called CarbFix, conducted about 540m deep in the rocks of
Iceland, offer new hope for an effective weapon to help fight man-made global
warming. When an international team of scientists pumped a carbon dioxide and water
mix into underground basalt rocks, basic chemistry took over. The acidic
mixture dissolved the rocks’ calcium magnesium and formed limestone, a
permanent natural jail for the heat-trapping gas.
Scientists,
who had done this before in the lab, thought the process could take thousands
or even hundreds of years. But after just two years, 95% of the gas, was
captured and converted. One of the methods to battle climate change, in
addition to reducing fossil fuel emissions, is to capture carbon dioxide from
the air or powerplants. Carbon capture is not the silver bullet, but it can
contribute significantly to reducing carbon dioxide emissions.
Carbon capture
however can be expensive – especially the capturing part. Once the gas is
grabbed from the air, storage is another issue. It can be stored underground, injected
in depleted oil wells, but there are concerns about monitoring it and
preventing it from escaping. Injecting it into basalt and letting nature take
its course can solve that problem. But at $17 per tonne of carbon dioxide, it
can cost a couple times more than injecting it into old wells. There’s basalt
all over the world, in places like the Pacific Northwest, India and South
America. But even more promising is the ocean floor, which is full of basalt and
a good place to store the carbon dioxide.
Saturday, 3 September 2016
Astrophysicists Discover Canarias Einstein Ring in Space
On 16
May 2016, an international team of astrophysicists discovered a new optical Einstein ring called
Canarias Einstein Ring. Einstein Ring is a distorted image of a galaxy, the
source, which is very distant from the Earth. The results of the discovery were
published in the international journal Monthly Notices of the Royal
Astronomical Society. The discovery was made by a team comprising of doctoral
student Margherita Bettinelli from the Instituto de Astrofisica de Canarias
(IAC) and the University of La Laguna (ULL) of Spain. The rare phenomenon was
discovered in the Sculptor constellation, IAC J010127-334319, in the vicinity
of the Sculptor Dwarf Spheroidal Galaxy
New Material Makes N-Fuel Recycling Cleaner, Cheaper
Scientists
have found a new material that may help recycle and reduce wastage of nuclear
fuels as well as save energy, making the reprocessing of radioactive materials
cleaner and less expensive. Conventional technologies to remove these
radioactive gases operate at extremely low, energy-intensive temperatures. By
working at ambient temperature, the new material – known as metal-organic
frameworks – can save energy, make reprocessing cleaner and less expensive. The
reclaimed materials can also be reused commercially.
A New DNA Treatment As The Future Of Cancer Treatment
A revolutionary
new DNA treatment technique makes you six times more likely to beat cancer. The
new technique involves having a simple £200(Rs 19,386) DNA test of your tumour
first. This them tells doctors precisely which drugs or therapies are most
suited to you, rather than relying on the standard treatment.
Precision
medicine studies presented at the American Society of Clinical Oncology annual
meeting are expected to show unprecedented results. One study of 13,000
patients taking part in early clinical trials of drugs found those undergoing
genetic testing of their tumours before any treatment – so that they could then
be given targeted therapies instead of standard drugs were six times more
likely to see their tumours shrink or disappear altogether. It is the first analysis
of precision medicine treatments.
It is a
very different way to treatment. It’s the most exciting thing since
chemotherapy. It was about using reliable technology to better treat patients and
giving them the most appropriate choice. Precision medicine was about finding
the right key for the lock, finding out what it is that is driving the tumour,
what make it tick. At the moment, it is informed guesswork, so that treatment
often doesn’t work for large numbers of patients. I believe the potential of
precision medicine is huge.
Universal Cancer Vaccine Gets a Step Closer
Scientists
have inched closer towards creating a universal vaccine against cancer that
makes the body’s immune system attack tumours as if they were a virus. An international
team of researchers described how they had taken pieces of cancer’s genetic RNA
code, put them into tiny nanoparticles of fat and then injected the mixture
into the blood streams of three patients in the advanced stages of the disease.
The patients’ immune systems responded by producing “killer” T-cells designed
to attack cancer. The vaccine was also found to be effective in fighting “aggressively
growing” tumours in mice.
Such vaccines are fast and
inexpensive to produce, and virtually any tumour antigen (a protein attacked by
the immune system) can be encoded by RNA. Thus, the nonoparticulate RNA immunotherapy
approach introduced here may be regarded as a universally applicable novel
vaccine class for cancer immunotherapy. The aim of trial was not to test how
well the vaccine worked. While the patients’ immune systems seemed to react, there
was no evidence that their cancers went away as a result. In one patient, a
suspected tumour on a lymph node got smaller. Another patient, whose tumours
had been surgically removed, was cancer-free seven months after vaccination. The
third patient had eight tumours that had spread from the initial skin cancer
into lungs. These tumours remained “clinically stable”.
The vaccine, which used different
pieces of RNA, activated dendritic cells that select target for the immune
system to attack, the vaccine also produced limited flu-like side effects in
contrast to the extreme sickness caused by chemotherapy. Cancer immunotherapy
is currently causing significant excitement in the medical community. It is
already being used to treat some cancers with a number of patients still in
remission more than 10 years after treatment. While traditional cancer treatment
for testicular and other form of the disease can lead to a complete cure, lung
cancer, melanoma, and some brain and neck cancers have proved difficult to
treat.
Immunotherapy for cancer is a
rapidly evolving and exciting field. This new study shows that an immune
response against the antigens within a cancer can be triggered by a new type of
cancer vaccine. There is uncertainty around whether the therapeutic benefit
seen in the mice will also apply to humans, and the practical challenge of
manufacturing nanoparticles for widespread clinical application.
Subscribe to:
Posts (Atom)






